Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 91
Filter
1.
Radiol Med ; 128(12): 1571-1579, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37642816

ABSTRACT

PURPOSE: Taste alteration (TA) is a frequent acute side effect of radiation treatment in HNSCC patients. Principal aim of our study was to investigate dosimetric parameters in relation to patient-assessed taste impairment in a prospective cohort treated with intensity-modulated radiotherapy. METHODS: All patients with locally advanced HNSCC and amenable to radical treatment were included. Chemotherapy-induced taste alteration scale (CITAS), EORTC QLQ-C30 and QLQ-HN43 questionnaires at baseline (T0), 3 weeks (T1) and 3 months (T2) after radiotherapy conclusion were used to assess taste impairment. Base of tongue, submandibular glands (SG), parotid glands (PG) and taste buds, along with anterior and medium third of the tongue, were considered as organs at risk and thus delineated according to consensus guidelines. The mean dose to the above-mentioned structures was correlated with patient-reported outcomes. RESULTS: Between September 2019 and November 2020, 33 patients were recruited, 31 of which analyzed. 71% had oropharyngeal carcinoma, mostly HPV-related (60%). All were treated with tomotherapy. 77.4% had concurrent cisplatin. Mean scores of general taste alterations, global health status and dry mouth and sticky saliva were assessed. The mean doses to the anterior third, medium third and base of the tongue were 23.85, 35.50 and 47.67 Gy, respectively. Taste buds received 32.72 Gy; right and left parotid 25 and 23 Gy; right and left submandibular glands 47.8 and 39.4 Gy. At univariate analysis, dysgeusia correlated with SG mean dose (95% CI 0-0.02 p = 0.05) and PG mean dose (95% CI 0-0.02 p = 0.05); dry mouth with mean dose to anterior (95% CI 0.03-1.47 p = 0.04) and medium third (95% CI 0.02-0.93 p = 0.04) of the tongue, to taste buds (95% CI 0.06-0.96 p = 0.03) and to SGs (95% CI 0.06-0.63 p = 0.02); pain mouth with mean dose to taste buds (95% CI 0-0.02 p = 0.04), to SGs (95% CI 0-0.03 p = 0.03) and to base tongue (95% CI 0-0.02 p = 0.02). CONCLUSIONS: Our analysis supports the influence of dose distribution on the development of TA in HNSCC patients. The contribution of dose to taste buds and tongue subvolumes remains unclear and worthy of further investigation.


Subject(s)
Head and Neck Neoplasms , Neoplasms, Squamous Cell , Radiotherapy, Intensity-Modulated , Xerostomia , Humans , Squamous Cell Carcinoma of Head and Neck , Prospective Studies , Dysgeusia/chemically induced , Taste , Head and Neck Neoplasms/radiotherapy , Xerostomia/etiology , Radiotherapy, Intensity-Modulated/adverse effects , Radiation Dosage , Neoplasms, Squamous Cell/etiology , Radiotherapy Dosage
2.
Mol Carcinog ; 60(3): 172-178, 2021 03.
Article in English | MEDLINE | ID: mdl-33482042

ABSTRACT

Although beta 2 adrenergic receptors (ß2 ADR) are present in the keratinocytes, their role in cutaneous squamous cell tumorigenesis needs to be ascertained. For the first time, we report here that selective ß2 ADR antagonists by inhibiting ß2 ADR actions significantly retarded the progression of ultraviolet B (UVB) induced premalignant cutaneous squamous cell lesions. These antagonists acted by inhibiting vascular endothelial growth factor-A (VEGF) mediated angiogenesis to prevent UVB radiation-induced squamous cell carcinoma of the skin.


Subject(s)
Adrenergic beta-2 Receptor Antagonists/pharmacology , Neoplasms, Squamous Cell/drug therapy , Skin Neoplasms/drug therapy , Ultraviolet Rays/adverse effects , Adrenergic beta-1 Receptor Agonists/pharmacology , Animals , Butoxamine/pharmacology , Humans , Keratinocytes/metabolism , Keratinocytes/radiation effects , Male , Mice, Inbred Strains , Neoplasms, Radiation-Induced/blood supply , Neoplasms, Radiation-Induced/drug therapy , Neoplasms, Radiation-Induced/etiology , Neoplasms, Squamous Cell/blood supply , Neoplasms, Squamous Cell/etiology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/metabolism , Receptors, Adrenergic, beta-2/metabolism , Skin Neoplasms/blood supply , Skin Neoplasms/etiology , Vascular Endothelial Growth Factor A/metabolism , Xamoterol/pharmacology
3.
Int J Gynaecol Obstet ; 151(2): 253-259, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32683675

ABSTRACT

OBJECTIVE: To determine the prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, Nigeria. METHODS: A cross-sectional study was conducted from October 2017 to January 2018 among 326 HIV-positive women. Cervical smears were collected for examination at the AIDS Preventive Initiative of Nigeria clinics of Jos University Teaching Hospital (JUTH) and Bingham University Teaching Hospital (BhUTH), Jos, Nigeria. Demographic characteristics of participants were documented using a structured questionnaire. Data were entered and analyzed using SPSS version 21. RESULTS: Of the 326 participants, precancerous cervical lesions were present in 40 (12.2%) women: 4 (1.2%) had atypical squamous cells of undetermined significance, 19 (5.8%) had low-grade squamous intraepithelial lesions, 1 (0.3%) had atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions, 13 (4.0%) had high-grade squamous intraepithelial lesions, and 3 (0.9%) had high-grade squamous intraepithelial lesions, suspected for invasion. The multivariate logistics regression model showed that parity (odds ratio 3.4, 95% confidence interval 1.3-9.5, P=0.043) was a significant predictor of precancerous cervical lesions. CONCLUSION: The prevalence of precancerous cervical lesions among HIV-infected women is relatively low compared to earlier reported prevalence in an HIV population in Jos. Increasing parity was a significant predictor.


Subject(s)
HIV Infections , HIV-1 , Neoplasms, Squamous Cell/epidemiology , Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Neoplasms/epidemiology , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Middle Aged , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Nigeria/epidemiology , Prevalence , Risk Factors , Socioeconomic Factors , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/pathology , Vaginal Smears , Young Adult , Uterine Cervical Dysplasia/etiology , Uterine Cervical Dysplasia/pathology
4.
Occup Environ Med ; 77(5): 293-300, 2020 05.
Article in English | MEDLINE | ID: mdl-31959638

ABSTRACT

OBJECTIVE: To investigate the association between occupational exposure to welding and the risk of head and neck cancer in a large French population-based case-control study, the Investigation of occupational and environmental CAuses of REspiratory cancers study. METHODS: Analyses were restricted to men (2703 controls and 1588 cases of squamous-cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx). Welding activity and potential confounders were assessed by detailed questionnaires. ORs and CIs (95% CI) were estimated by unconditional logistic regression, adjusted for age, area of residence, tobacco smoking, alcohol consumption and occupational exposure to asbestos. RESULTS: Welding was associated with an increased risk of head and neck cancer overall (OR=1.31, 95% CI 1.03 to 1.67). The association was strongest for laryngeal cancer (OR=1.66, 95% CI 1.15 to 2.38) and the risk increased with the cumulative duration (p-trend <0.01) and the weighted duration (p-trend <0.01) of welding. A cumulative duration and a weighted duration of welding of more than 10 years were also associated with a significantly increased risk of oral cancer (OR=1.82, 95% CI 1.09 to 3.04; OR=2.10, 95% CI 0.99 to 4.45, respectively). A long duration of arc welding was associated with laryngeal cancer, whereas a long duration of spot welding was associated with oral cancer. Welding was not associated with the risk of oropharyngeal and hypopharyngeal cancer. CONCLUSION: Our findings suggest that welding and several welding-related tasks increase the risk of laryngeal cancer and to a lesser extent oral cancer.


Subject(s)
Laryngeal Neoplasms/epidemiology , Neoplasms, Squamous Cell/epidemiology , Occupational Diseases/epidemiology , Occupational Exposure/adverse effects , Pharyngeal Neoplasms/epidemiology , Welding , Adolescent , Adult , Aged , Case-Control Studies , France/epidemiology , Head and Neck Neoplasms , Humans , Hypopharyngeal Neoplasms , Laryngeal Neoplasms/etiology , Laryngeal Neoplasms/pathology , Logistic Models , Male , Middle Aged , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Occupational Diseases/etiology , Occupational Diseases/pathology , Oropharyngeal Neoplasms , Pharyngeal Neoplasms/etiology , Pharyngeal Neoplasms/pathology , Risk Factors , Young Adult
5.
Oral Oncol ; 97: 137-138, 2019 10.
Article in English | MEDLINE | ID: mdl-31445773

ABSTRACT

For patients with Lynch Syndrome (LS) (formerly known as hereditary nonpolyposis colorectal cancer or HNPCC), inheritance of one of several mutated mismatch repair genes (MMR) results in an increased risk for a variety of malignancies including colon, rectal, endometrial, urinary tract, gastric, small bowel and others [1]. Confirmation of increased risk of particular malignancies for patients harboring an MMR germline mutation has typically been the result of population studies of families tracked for the development of the possible associated cancer. When cancer results from inheritance of a particular mutated MMR gene, the malignancy has a characteristic fingerprint referred to as microsatellite instability-high (MSI-H), which results from deficient expression of the inherited MMR gene product (dMMR). Therefore, if sporadic tumors of a particular tissue of origin are only rarely dMMR, identifying a tumor as dMMR in a known LS family member suggests that, in that particular family, inheritance of the mutated MMR gene does predispose to that malignancy. Here we describe a patient diagnosed with a germline mutation in the MMR gene MSH6 who developed an oral pharynx cancer. Oral pharynx cancers are not known to be associated with LS. By confirming that the tumor was not dMMR and not MSI-H, it was concluded that his oral pharynx cancer was sporadic, rather than LS-related, and other family members carrying the mutated MSH6 are unlikely to be at above-average risk for the development of oral cancers, as a result of the LS. In additional, he would not be eligible for the so-called FDA agnostic approved immunotherapy which is endorsed for dMMR or MSI-H tumors [2].


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/complications , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Mouth Neoplasms/etiology , Mouth Neoplasms/genetics , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/genetics , Aged , Genetic Predisposition to Disease/genetics , Germ-Line Mutation/genetics , Humans , Male , Risk
7.
J Cancer Res Clin Oncol ; 144(3): 607-615, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29362916

ABSTRACT

PURPOSE: Non-melanoma skin cancer (NMSC) is the most common de novo malignancy in liver transplant (LT) recipients; it behaves more aggressively and it increases mortality. We used decision tree analysis to develop a tool to stratify and quantify risk of NMSC in LT recipients. METHODS: We performed Cox regression analysis to identify which predictive variables to enter into the decision tree analysis. Data were from the Organ Procurement Transplant Network (OPTN) STAR files of September 2016 (n = 102984). RESULTS: NMSC developed in 4556 of the 105984 recipients, a mean of 5.6 years after transplant. The 5/10/20-year rates of NMSC were 2.9/6.3/13.5%, respectively. Cox regression identified male gender, Caucasian race, age, body mass index (BMI) at LT, and sirolimus use as key predictive or protective factors for NMSC. These factors were entered into a decision tree analysis. The final tree stratified non-Caucasians as low risk (0.8%), and Caucasian males > 47 years, BMI < 40 who did not receive sirolimus, as high risk (7.3% cumulative incidence of NMSC). The predictions in the derivation set were almost identical to those in the validation set (r2 = 0.971, p < 0.0001). Cumulative incidence of NMSC in low, moderate and high risk groups at 5/10/20 year was 0.5/1.2/3.3, 2.1/4.8/11.7 and 5.6/11.6/23.1% (p < 0.0001). CONCLUSIONS: The decision tree model accurately stratifies the risk of developing NMSC in the long-term after LT.


Subject(s)
Decision Support Techniques , Decision Trees , Liver Transplantation/adverse effects , Skin Neoplasms/etiology , Adult , Aged , Female , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Liver Transplantation/statistics & numerical data , Male , Middle Aged , Neoplasms, Basal Cell/epidemiology , Neoplasms, Basal Cell/etiology , Neoplasms, Squamous Cell/epidemiology , Neoplasms, Squamous Cell/etiology , Risk Assessment , Risk Factors , Skin Neoplasms/epidemiology , Transplantation Conditioning/adverse effects , Transplantation Conditioning/statistics & numerical data
8.
Cornea ; 36(6): 743-746, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28350623

ABSTRACT

PURPOSE: To discuss the association between ocular surface squamous neoplasia (OSSN) and Papillon-Lefèvre syndrome (PLS) and present the long-term outcome in a patient with these diseases. METHODS: Case report. RESULTS: A 14-year-old boy presented with a raised pigmented mass lesion at the limbus in the right eye, which was clinically suggestive of OSSN. He also had palmoplantar hyperkeratosis and periodontosis suggestive of PLS. Excision biopsy of the lesion confirmed the diagnosis of OSSN. He was free of tumor recurrence for 2 years and was lost to follow-up thereafter. Seven years later, the patient presented with diffuse tumor recurrence with orbital extension in the right eye, regional lymph node metastasis, and ipsilateral parotid gland infiltration. The patient underwent exenteration of the right orbital contents, right parotidectomy, and radical neck dissection followed by concomitant external beam radiotherapy and systemic chemotherapy. Eleven years from initial presentation, the patient was detected to have OSSN in the contralateral eye and was managed by wide excision biopsy and adjuvant cryotherapy. One year after detection of OSSN in the left eye, the patient was found to have systemic metastases to the lungs and brain. The patient died of the disease within 3 months of detection of systemic metastasis. CONCLUSIONS: OSSN in PLS is associated with poor prognosis.


Subject(s)
Corneal Diseases/etiology , Eye Neoplasms/etiology , Limbus Corneae/pathology , Neoplasms, Squamous Cell/etiology , Papillon-Lefevre Disease/complications , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Brachytherapy , Combined Modality Therapy , Corneal Diseases/pathology , Corneal Diseases/therapy , Eye Neoplasms/pathology , Eye Neoplasms/therapy , Fatal Outcome , Follow-Up Studies , Humans , Male , Neoplasms, Squamous Cell/pathology , Neoplasms, Squamous Cell/therapy , Retrospective Studies
9.
Cancer Sci ; 108(5): 1058-1064, 2017 May.
Article in English | MEDLINE | ID: mdl-28218985

ABSTRACT

Soft palatal melanosis can be detected by visual inspection during routine physical examination or even personally in a mirror. The aim of this study was to evaluate the association between squamous cell neoplasia in the upper aerodigestive tract (UAT) and soft palatal melanosis. We reviewed digitized records of high-quality endoscopic images of the soft palate of 1786 Japanese alcoholic men who underwent endoscopic screening. Soft palatal melanosis was observed in 381 (21.3%) of the subjects (distinct, 6.3%). Older age, an inactive heterozygous aldehyde dehydrogenase-2 genotype, smoking, and a high mean corpuscular volume were positively associated with the presence of soft palatal melanosis. The age-adjusted odds ratio (95% confidence interval) for UAT neoplasia was 1.92 (1.40-2.64) in the group with melanosis and 2.51 (1.55-4.06) in the group with distinct melanosis, compared with the melanosis-free group. A multivariate analysis showed that the presence of soft palatal melanosis was independently associated with a high risk of UAT neoplasia. We calculated the individual number of risk factors out of four easily identifiable and significant factors: age ≥55 years, current/former alcohol flushing, mean corpuscular volume ≥106 fL, and distinct soft palatal melanosis. Compared with the risk-factor-free condition, the odds ratio (95% confidence interval) values of UAT neoplasia for one, two, three, and four risk factors were 1.49 (0.97-2.30), 3.14 (2.02-4.88), 4.80 (2.71-8.51), and 7.80 (2.17-28.1), respectively. The presence of soft palatal melanosis provides a simple new strategy for identifying heavy drinkers with a high risk for UAT neoplasia.


Subject(s)
Head and Neck Neoplasms/etiology , Head and Neck Neoplasms/pathology , Melanosis/complications , Melanosis/pathology , Palate, Soft/pathology , Adult , Aged , Alcohol Drinking/adverse effects , Aldehyde Dehydrogenase/metabolism , Asian People , Humans , Male , Melanosis/etiology , Middle Aged , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Odds Ratio , Risk Factors , Smoking/adverse effects
10.
Photodiagnosis Photodyn Ther ; 17: 200-204, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27174210

ABSTRACT

INTRODUCTION: Photodynamic therapy (PDT) is a minimally invasive intervention used in the management of tissue disorders. In this retrospective study, a total of 62 patients with actinic keratosis (AKs) were treated with surface illumination PDT. Comparisons with the clinical features, rate of recurrence as well as malignant transformation and overall outcome were made. MATERIALS AND METHODS: The medical records of 62 consecutive patients who presented with suspicious skin lesions and diagnosed with AKs were examined. These patients with 178 AKs lesions were treated with surface illumination methyl aminolevulinate-photodynamic therapy (MAL-PDT). The 16% strength cream (MAL) was applied topically 3h prior to tissue illumination. A single-channel 628nm diode laser was used for illumination and light was delivered at 100J/cm2 per site. These patients were followed-up for a mean of 7.4 years. RESULTS: Eight recurrences were reported after the first round of MAL-PDT, and two recurrences after the second round. Malignant transformation to squamous cell carcinoma (SCC) was noted in 2 patients only. The 3-year outcome resulted in 60 patients with complete response (CR), and this was maintained at the final outcome (last clinic review). Assessment of lesional outcome vs. response showed that 175/178 treated lesions had complete response (CR) at 3-year follow-up, which increased to 176/178 lesions at the last clinic follow-up. CONCLUSION: MAL-PDT offers an effective treatment for AKs lesions with excellent cosmetic outcome.


Subject(s)
Aminolevulinic Acid/analogs & derivatives , Keratosis, Actinic/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Aged , Aminolevulinic Acid/therapeutic use , Female , Humans , Keratosis, Actinic/complications , Male , Middle Aged , Neoplasms, Squamous Cell/etiology , Photochemotherapy/adverse effects , Recurrence , Retrospective Studies , Risk Factors
11.
Proc Natl Acad Sci U S A ; 113(27): 7614-9, 2016 07 05.
Article in English | MEDLINE | ID: mdl-27335465

ABSTRACT

The etiology of peripheral squamous cell lung cancer (PSCCa) remains unknown. Here, we show that this condition spontaneously develops in mice in which the genes for two oxysterol receptors, Liver X Receptor (LXR) α (Nr1h3) and ß (Nr1h2), are inactivated. By 1 y of age, most of these mice have to be euthanized because of severe dyspnea. Starting at 3 mo, the lungs of LXRα,ß(Dko) mice, but not of LXRα or LXRß single knockout mice, progressively accumulate foam cells, so that by 1 y, the lungs are covered by a "golden coat." There is infiltration of inflammatory cells and progressive accumulation of lipid in the alveolar wall, type 2 pneumocytes, and macrophages. By 14 mo, there are three histological lesions: one resembling adenomatous hyperplasia, one squamous metaplasia, and one squamous cell carcinoma characterized by expression of transformation-related protein (p63), sex determining region Y-box 2 (Sox2), cytokeratin 14 (CK14), and cytokeratin 13 (CK13) and absence of thyroid transcription factor 1 (TTF1), and prosurfactant protein C (pro-SPC). RNA sequencing analysis at 12 mo confirmed a massive increase in markers of M1 macrophages and lymphocytes. The data suggest a previously unidentified etiology of PSCCa: cholesterol dysregulation and M1 macrophage-predominant lung inflammation combined with damage to, and aberrant repair of, lung tissue, particularly the peripheral parenchyma. The results raise the possibility that components of the LXR signaling may be useful targets in the treatment of PSCCa.


Subject(s)
Lipid Metabolism , Liver X Receptors/physiology , Lung Neoplasms/etiology , Lung/metabolism , Neoplasms, Squamous Cell/etiology , Alveolar Epithelial Cells/metabolism , Animals , Fibroblasts/metabolism , Homeostasis , Lung/pathology , Macrophages/metabolism , Mice, Inbred C57BL , Pneumonia/etiology , Sequence Analysis, RNA
12.
Ann Epidemiol ; 25(4): 293-296.e2, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25560876

ABSTRACT

PURPOSE: Human papillomavirus' (HPV's) role in skin cancer is controversial. To examine whether an individual is prone to develop a chronic oncogenic infection, we conducted a nationwide population-based cohort study of the risk of skin cancer after another HPV-related neoplasia-that is, cervical high-grade dysplasia or carcinoma-using cervical conization as a surrogate marker. METHODS: Using Danish registries, we identified all women who underwent conization from 1978 to 2011 (n = 87,164) and followed them until first-time skin cancer diagnosis, death, emigration, or 31 December 2011, whichever came first. We calculated standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma (MM) according to national incidence rates. RESULTS: The 1-year absolute risks were 0.0012%, 0.045%, and 0.029% for SCC, BCC, and MM, respectively. Conization was clearly associated with increased incidence of SCC (SIR = 1.37; 95% CI: 1.13-1.65), but not MM (SIR = 1.00; 95% CI: 0.91-1.11). BCC risk was slightly increased (SIR = 1.08; 95% CI: 1.02-1.13). CONCLUSIONS: The association between conization and cutaneous SCC provides evidence for conization as a marker of underlying general susceptibility to oncogenic HPV.


Subject(s)
Cervix Uteri/pathology , Melanoma/etiology , Papillomavirus Infections/complications , Skin Neoplasms/etiology , Uterine Cervical Dysplasia/epidemiology , Adult , Aged , Biomarkers , Carcinoma, Basal Cell/etiology , Carcinoma, Basal Cell/virology , Cervix Uteri/virology , Cohort Studies , Conization , Denmark/epidemiology , Female , Humans , Incidence , Melanoma/virology , Middle Aged , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/virology , Risk Factors , Skin Neoplasms/virology , Uterine Cervical Dysplasia/virology
13.
PLoS Genet ; 10(10): e1004721, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25329316

ABSTRACT

Exposure to ultraviolet (UV) radiation from sunlight accounts for 90% of the symptoms of premature skin aging and skin cancer. The tumor suppressor serine-threonine kinase LKB1 is mutated in Peutz-Jeghers syndrome and in a spectrum of epithelial cancers whose etiology suggests a cooperation with environmental insults. Here we analyzed the role of LKB1 in a UV-dependent mouse skin cancer model and show that LKB1 haploinsufficiency is enough to impede UVB-induced DNA damage repair, contributing to tumor development driven by aberrant growth factor signaling. We demonstrate that LKB1 and its downstream kinase NUAK1 bind to CDKN1A. In response to UVB irradiation, LKB1 together with NUAK1 phosphorylates CDKN1A regulating the DNA damage response. Upon UVB treatment, LKB1 or NUAK1 deficiency results in CDKN1A accumulation, impaired DNA repair and resistance to apoptosis. Importantly, analysis of human tumor samples suggests that LKB1 mutational status could be a prognostic risk factor for UV-induced skin cancer. Altogether, our results identify LKB1 as a DNA damage sensor protein regulating skin UV-induced DNA damage response.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/metabolism , DNA Damage/radiation effects , Protein Serine-Threonine Kinases/metabolism , Ultraviolet Rays/adverse effects , AMP-Activated Protein Kinases , Animals , Animals, Newborn , Apoptosis/genetics , Apoptosis/radiation effects , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p21/genetics , Disease Models, Animal , Hepatocyte Growth Factor/genetics , Humans , Keratinocytes/metabolism , Keratinocytes/pathology , Keratinocytes/radiation effects , Mice, Transgenic , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Phosphorylation , Protein Kinases/metabolism , Protein Serine-Threonine Kinases/genetics , Repressor Proteins/metabolism , Skin Neoplasms/etiology , Skin Neoplasms/genetics , Skin Neoplasms/pathology
14.
Arch Environ Occup Health ; 69(1): 3-10, 2014.
Article in English | MEDLINE | ID: mdl-23930791

ABSTRACT

The authors examined the associations between farming and the risk for squamous cell (SCC) or urothelial cell (UC) carcinoma of the urinary bladder among Egyptians. The authors used data from a multicenter case-control study (1,525 male and 315 female cases, and 2,069 male and 547 female age- and residence-matched, population-based controls) to calculate adjusted odds ratios (AORs) and 95% confidence intervals (CIs). Men in farming and who never smoked had increased risk for either SCC or UC (AOR [95% CI]: 4.65 [2.59-8.36] and 6.22 [3.82-10.15], respectively). If they ever smoked, their risks were 2.27 (1.75-2.95) and 1.93 (1.58-2.35), respectively. Women in farmer households were at increased risk for SCC (1.40 [0.93-2.09] and UC [1.25 (0.82-1.89]), although not statistically significant. Occupational and environmental exposures to farming increased the risk for bladder cancer among Egyptians.


Subject(s)
Agricultural Workers' Diseases/epidemiology , Urinary Bladder Neoplasms/epidemiology , Agricultural Workers' Diseases/etiology , Carcinoma/epidemiology , Carcinoma/etiology , Case-Control Studies , Chi-Square Distribution , Egypt/epidemiology , Female , Humans , Logistic Models , Male , Middle Aged , Neoplasms, Squamous Cell/epidemiology , Neoplasms, Squamous Cell/etiology , Occupational Exposure/adverse effects , Occupational Exposure/statistics & numerical data , Odds Ratio , Risk Factors , Smoking/adverse effects , Urinary Bladder Neoplasms/etiology
16.
Semin Respir Crit Care Med ; 34(3): 371-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23821511

ABSTRACT

Fungal infections continue to produce morbidity and mortality in lung transplant recipients despite the widespread use of antifungal prophylaxis. There has been a decline in Candida infections but Aspergillus species predominate. Other mold pathogens including Fusarium, Scedosporium, and Zygomycetes also cause infections in lung transplant recipients. Furthermore, the widespread use of antifungal prophylaxis has prompted a delay in onset of Aspergillus infection in lung transplant recipients. Pulmonary parenchymal disease has become the most common manifestation of invasive aspergillosis. Among the risk factors pre- or posttransplant Aspergillus colonization is the most important risk factor reported in several retrospective studies. Recently posttransplant colonization has been implicated in the development of bronchiolitis obliterans syndrome. Other factors that have been reported include preceding cytomegalovirus infections, hypogammaglobulinemia, and single-lung transplantation. The risk factors for other mold infections such as Scedosporium, Fusarium, and Zygomycetes are not well studied. The best antimold prophylaxis strategy and choice of drug remains to be elucidated. Most lung transplant centers use either voriconazole or inhaled amphotericin preparations. However, data have emerged regarding the increased risk of squamous cell cancer in lung transplant recipients on voriconazole prophylaxis. Advances in the diagnosis and treatment of invasive aspergillosis have resulted in a significant decrease in mortality.


Subject(s)
Antifungal Agents/therapeutic use , Lung Diseases, Fungal/epidemiology , Lung Transplantation/methods , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antifungal Agents/administration & dosage , Antifungal Agents/adverse effects , Aspergillosis/epidemiology , Aspergillosis/etiology , Aspergillosis/therapy , Bronchiolitis Obliterans/epidemiology , Bronchiolitis Obliterans/microbiology , Fungi/isolation & purification , Humans , Lung Diseases, Fungal/microbiology , Lung Diseases, Fungal/prevention & control , Neoplasms, Squamous Cell/epidemiology , Neoplasms, Squamous Cell/etiology , Pyrimidines/adverse effects , Pyrimidines/therapeutic use , Risk Factors , Triazoles/adverse effects , Triazoles/therapeutic use , Voriconazole
19.
Neuropathology ; 32(2): 171-3, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21692865

ABSTRACT

Craniopharyngiomas are histopathologically classified as adamantinomatous type (AD) and squamous-papillary type (SP). However coexistence of a mixed type seen on histopathologic specimens has not been reported. In this report, a patient diagnosed with mixed type craniopharyngioma is presented and the etiology and pathologic features are discussed.


Subject(s)
Craniopharyngioma/etiology , Craniopharyngioma/pathology , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Pituitary Neoplasms/etiology , Pituitary Neoplasms/pathology , Aged, 80 and over , Craniopharyngioma/complications , Humans , Male , Neoplasms, Squamous Cell/complications , Pituitary Neoplasms/complications
20.
Int J Cancer ; 130(12): 2949-60, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-21796615

ABSTRACT

We investigated the development of esophageal neoplasia in biopsy specimens of the distinct iodine-unstained lesions (DIULs) ≥ 5 mm detected in 280 of 2,115 Japanese alcoholic men who underwent screening by esophageal iodine staining. Low-grade intraepithelial neoplasia (LGIN) was diagnosed in 155 of them, high-grade intraepithelial neoplasia (HGIN) in 57, and invasive SCC in 35. The size of the DIULs increased with the degree of neoplasia. Most LGINs were flat and were missed before iodine staining. Some DIULs became a light pink color (PC) about 2 min after staining, and 2.6, 56.1 and 96.0% of the LGIN, HGIN and invasive SCC lesions, respectively, were PC-sign-positive. Multiple DIULs of any size markedly increased the risk of LGIN [adjusted OR (95%CI) = 10.1 (7.12-14.5)], HGIN [27.9 (14.6-53.4)] and invasive SCC [21.6 (10.1-46.4)], and were strongly associated with the presence vs. absence of DIULs ≥ 5 mm [13.3 (9.21-19.1)], inactive heterozygous aldehyde dehydrogenase-2 (ALDH2*1/*2) vs. ALDH2*1/*1 [2.60 (1.79-3.78)], and less-active alcohol dehydrogenase-1B (ADH1B*1/*1) vs. ADH1B*2 allele [2.61 (1.87-3.64)]. The combination of ALDH2*1/*2 and ADH1B*1/*1 synergistically increased the risk of LGIN [4.53 (2.17-9.47)], HGIN [10.4 (4.34-24.7)] and invasive SCC [21.7 (7.96-59.3)]. Esophageal neoplasia developed at earlier ages in those with ALDH2*1/*2. Biopsy-proven HGIN was diagnosed as invasive SCC in 15 (39.5%) of 38 patients after endoscopic mucosectomy or surgery. In conclusion, large size, non-flat appearance, positive PC sign and multiplicity of DIULs and ALDH2*1/*2 and ADH1B*1/*1 were associated with development of esophageal neoplasia in Japanese alcoholics. Biopsy-proven HGIN should be totally resected for both diagnostic and therapeutic purposes.


Subject(s)
Alcoholics , Alcoholism/complications , Aldehyde Dehydrogenase/genetics , Esophageal Neoplasms/genetics , Esophagus/pathology , Neoplasms, Squamous Cell/genetics , Sugar Alcohol Dehydrogenases/genetics , Adult , Aged , Aged, 80 and over , Alcoholism/genetics , Carcinoma in Situ/genetics , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/etiology , Esophageal Neoplasms/pathology , Genotype , Humans , Japan , Male , Middle Aged , Neoplasms, Squamous Cell/diagnosis , Neoplasms, Squamous Cell/etiology , Neoplasms, Squamous Cell/pathology , Risk Factors , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...